The structure based design of dual HDAC/BET inhibitors as novel epigenetic probes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The structure based design of dual HDAC/BET inhibitors as novel epigenetic probes
Authors
Keywords
-
Journal
MedChemComm
Volume 5, Issue 3, Pages 342
Publisher
Royal Society of Chemistry (RSC)
Online
2014-01-29
DOI
10.1039/c3md00285c
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML)
- (2015) Harald Herrmann et al. Oncotarget
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Super-Enhancers in the Control of Cell Identity and Disease
- (2013) Denes Hnisz et al. CELL
- Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
- (2013) Olivier Mirguet et al. JOURNAL OF MEDICINAL CHEMISTRY
- Remodeling of the Enhancer Landscape during Macrophage Activation Is Coupled to Enhancer Transcription
- (2013) Minna U. Kaikkonen et al. MOLECULAR CELL
- BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models
- (2013) Anastasia Wyce et al. PLoS One
- From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151
- (2012) Olivier Mirguet et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)
- (2012) Jonathan Seal et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy
- (2012) M. Chesi et al. BLOOD
- Place your BETs: the therapeutic potential of bromodomains
- (2012) R.K. Prinjha et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Differentiation of NUT Midline Carcinoma by Epigenomic Reprogramming
- (2011) B. E. Schwartz et al. CANCER RESEARCH
- Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity
- (2011) Robert J. Young et al. DRUG DISCOVERY TODAY
- Bromodomains as therapeutic targets
- (2011) Susanne Muller et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains
- (2011) Chun-wa Chung et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery
- (2011) Chun-wa Chung et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides
- (2011) Paul Bamborough et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
- (2011) Marcus Bantscheff et al. NATURE BIOTECHNOLOGY
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylases as regulators of inflammation and immunity
- (2011) Melanie R. Shakespear et al. TRENDS IN IMMUNOLOGY
- Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity
- (2010) Alan P. Hill et al. DRUG DISCOVERY TODAY
- Biological and Biophysical Properties of the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Are Affected by the Presence of Short Alkyl Groups on the Phenyl Ring
- (2010) Frédérik Oger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Suppression of inflammation by a synthetic histone mimic
- (2010) Edwige Nicodeme et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- Muscarinic antagonist-β-adrenergic agonist dual pharmacology molecules as bronchodilators: a patent review
- (2009) Nicholas C Ray et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Proteomics strategy for quantitative protein interaction profiling in cell extracts
- (2009) Kirti Sharma et al. NATURE METHODS
- Chemical target and pathway toxicity mechanisms defined in primary human cell systems
- (2009) Ellen L. Berg et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started